Research Education

Peptide Education

A comprehensive guide to understanding peptides - what they are, how they work, the different types used in research, proper administration and storage, and a complete 99-term glossary.

What Are Peptides How They Work Types Administration Safety & Storage FAQ Verified Source Glossary

What Are Peptides

Peptide chain molecular structure illustration

Peptides are short chains of amino acids - the same building blocks that make up proteins - linked together by chemical bonds called peptide bonds. While proteins typically contain 50 or more amino acids folded into complex three-dimensional structures, peptides are smaller, usually ranging from 2 to 50 amino acids in length. This smaller size gives peptides unique properties: they can be highly specific in their biological activity, rapidly absorbed by the body, and precisely targeted to particular receptors and tissues.

20
Standard amino acids serve as the building blocks for all peptides and proteins in the human body
7,000+
Naturally occurring peptides have been identified in the human body, each with distinct biological functions
2-50
Amino acids in length is the typical range that defines a peptide, distinguishing it from larger proteins

Your body naturally produces thousands of peptides that act as hormones, neurotransmitters, and signaling molecules. Insulin, a 51-amino-acid peptide produced by the pancreas, regulates blood sugar. Oxytocin, a 9-amino-acid peptide, influences social bonding and reproductive processes. Growth hormone-releasing hormone (GHRH) signals the pituitary gland to produce growth hormone. These endogenous peptides orchestrate virtually every physiological process - from immune defense and tissue repair to metabolism and cognitive function.

Research peptides are synthetic versions of these natural molecules, or novel sequences designed to interact with specific biological targets. By understanding the structure and function of endogenous peptides, researchers have developed synthetic analogs that can mimic, enhance, or modulate the body's own signaling systems with remarkable precision.

Key distinction
Peptide (2-50 amino acids) vs. Polypeptide (50-100+ amino acids) vs. Protein (100+ amino acids with complex 3D folding). The boundaries are not rigid - what matters is that peptides are small enough to act as precise molecular signals without the structural complexity of full proteins.

How Peptides Work

Peptide receptor binding and cell signaling illustration

Peptides exert their biological effects through a process called receptor binding. Every cell in the body has receptors on its surface - protein structures that act as molecular locks. When a peptide with the right shape (the key) binds to a receptor, it triggers an intracellular signaling cascade: a chain of molecular events inside the cell that ultimately produces the peptide's therapeutic effect.

01
Binding
The peptide binds to a specific receptor on the target cell's surface. This interaction is highly selective - each peptide fits only certain receptor types, which is why different peptides have different effects.
02
Signal transduction
Receptor activation triggers a cascade of intracellular signals. Enzymes are activated, second messengers are released, and transcription factors are mobilized - amplifying the initial signal many times over.
03
Cellular response
The signaling cascade produces measurable biological effects: gene expression changes, protein synthesis, hormone release, or cellular repair mechanisms. The specific response depends on the receptor type and cell involved.
04
Regulation
The body regulates peptide activity through feedback mechanisms. Receptors may become desensitized after prolonged exposure, and enzymes break down the peptide to terminate the signal. This is why cycling protocols matter.

This receptor-based mechanism is what makes peptides fundamentally different from nutrients or general supplements. Rather than providing raw materials for the body to use, peptides deliver specific molecular instructions. A growth hormone secretagogue, for example, doesn't supply growth hormone directly - it binds to receptors on the pituitary gland and instructs it to produce and release more of its own growth hormone, preserving the body's natural pulsatile rhythm.

The specificity of peptide-receptor interactions also explains why different peptides can target very different systems. BPC-157 activates pathways involved in tissue repair and angiogenesis. Thymosin Alpha-1 binds to immune cell receptors to modulate immune function. Semaglutide targets GLP-1 receptors in the gut and brain to influence appetite and glucose metabolism. Each peptide has its own receptor profile, which determines its unique set of biological effects.

Types of Peptides

Diverse peptide molecular structures illustration

Peptides studied in research contexts span a wide range of biological targets and mechanisms. While the boundaries between categories are not absolute - many peptides have effects across multiple systems - the following classification reflects their primary research applications.

Growth Hormone
GH Secretagogues
Peptides that stimulate the pituitary gland to produce and release growth hormone naturally. Rather than introducing exogenous GH, these compounds work with the body's own endocrine system to enhance GH output while maintaining pulsatile release patterns.
CJC-1295, Ipamorelin, GHRP-2, GHRP-6, Sermorelin, Tesamorelin, Hexarelin
Recovery
Healing & Recovery
Peptides researched for their ability to accelerate tissue repair, reduce inflammation, and support recovery from injury. These compounds often work by promoting angiogenesis, collagen synthesis, and cellular repair mechanisms.
BPC-157, TB-500, GHK-Cu, KPV, Pentadecarginine, AOD-9604
Metabolic
Metabolic & Weight Management
Peptides that target metabolic pathways including glucose regulation, appetite signaling, and fat metabolism. Several of these are among the most clinically advanced peptides, with some achieving FDA approval for specific indications.
Semaglutide, Tirzepatide, Retatrutide, Tesofensine, MOTS-c, 5-Amino-1MQ
Cognitive
Cognitive & Neuroprotective
Peptides studied for effects on brain function, neuroprotection, and cognitive enhancement. Many of these cross the blood-brain barrier via intranasal administration to directly influence neural tissue.
Semax, Selank, Cerebrolysin, Dihexa, BPC-157 (neuro), PE-22-28
Longevity
Longevity & Anti-Aging
Peptides that target fundamental aging mechanisms including telomere maintenance, mitochondrial function, cellular senescence, and NAD+ metabolism. These represent some of the most forward-looking areas of peptide research.
Epitalon, NAD+, SS-31 (Elamipretide), FOXO4-DRI, Humanin, GHK-Cu
Immune
Immune Modulation
Peptides that regulate immune function - either enhancing immune response against pathogens or modulating overactive immune pathways. These are particularly relevant in the context of autoimmune conditions and chronic infection.
Thymosin Alpha-1, LL-37, Thymalin, KPV, BPC-157 (immune)
Hormonal
Hormonal & Reproductive
Peptides involved in reproductive hormone regulation, sexual function, and endocrine balance. These interact with the hypothalamic-pituitary-gonadal axis and related receptor systems.
Kisspeptin-10, PT-141 (Bremelanotide), Gonadorelin, HCG
Aesthetic
Aesthetic & Dermatological
Peptides researched for skin health, hair growth, and cosmetic applications. These typically work through collagen stimulation, melanogenesis, or growth factor activation at the dermal level.
GHK-Cu, Melanotan I/II, Copper peptides, PTD-DBM

Administration Routes

Peptide administration equipment illustration

How a peptide is administered significantly affects its bioavailability, onset time, and overall efficacy. Different peptides require different routes based on their molecular properties, target tissues, and susceptibility to enzymatic breakdown. Understanding these routes is essential for any peptide research protocol.

Subcutaneous (SC)
Most common
Injection into the fatty tissue layer just beneath the skin, typically in the abdomen, thigh, or upper arm. The peptide absorbs gradually into the bloodstream through surrounding capillaries.
Bioavailability 65-95%
Onset 15-30 min
Needle 28-31G, 1/2"
Best for: Most peptides including BPC-157, GH secretagogues, metabolic peptides. Easy self-administration, sustained absorption.
Intramuscular (IM)
Faster absorption
Injection directly into a muscle such as the deltoid, vastus lateralis, or gluteus. Higher blood flow in muscle tissue provides faster and more complete absorption compared to subcutaneous injection.
Bioavailability 75-100%
Onset 5-15 min
Needle 22-25G, 1-1.5"
Best for: Larger volume injections, peptides requiring rapid systemic distribution. NAD+, Cerebrolysin, and some GH peptides.
Intranasal
Brain-targeted
Administration through the nasal mucosa via spray or drops. The nasal cavity provides a direct pathway to the central nervous system through the olfactory and trigeminal nerve pathways, partially bypassing the blood-brain barrier.
Bioavailability 10-50%
Onset 5-15 min
Equipment Nasal spray
Best for: Cognitive and neuroprotective peptides including Semax, Selank, and NAD+ (nasal formulations).
Intravenous (IV)
Clinical setting
Direct administration into a vein, providing immediate and complete systemic distribution. This route is typically reserved for clinical or supervised settings due to the expertise and sterile conditions required.
Bioavailability 100%
Onset Immediate
Setting Clinical only
Best for: NAD+ infusions, Cerebrolysin, and peptides requiring precise dosing control. Requires clinical supervision.
Oral
Limited use
Taken by mouth in capsule or tablet form. Most peptides have very low oral bioavailability because digestive enzymes break them down and first-pass liver metabolism further reduces the amount reaching systemic circulation.
Bioavailability 1-10%
Onset 30-60 min
Equipment None
Best for: BPC-157 (gastric protection), oral semaglutide (specially formulated). Most peptides are ineffective orally.
Topical
Localized
Applied directly to the skin as a cream, serum, or gel for localized effects. Topical peptides are primarily used for dermatological applications where the target tissue is the skin itself.
Bioavailability Local
Onset Variable
Equipment None
Best for: GHK-Cu (skin rejuvenation, wound healing), copper peptides, and other dermatological peptides.

Safety & Storage

Peptide storage and cold chain illustration

Proper handling, storage, and administration practices are critical for maintaining peptide stability and ensuring research integrity. Peptides are delicate molecules that can lose their biological activity through heat exposure, physical agitation, microbial contamination, or chemical degradation.

Reconstitution

Most research peptides arrive as lyophilized (freeze-dried) powder and must be reconstituted before use. The standard diluent is bacteriostatic water (BAC water) - sterile water containing 0.9% benzyl alcohol as a preservative.

  • Swab the vial stopper with an alcohol wipe before inserting the needle
  • Draw the appropriate volume of BAC water into a syringe
  • Insert the needle into the vial and direct the water gently down the inner wall
  • Never squirt water directly onto the powder - this causes foaming and denaturation
  • Allow the powder to dissolve naturally; gently swirl if needed, never shake
  • The solution should be clear - discard if cloudy or discolored
Storage conditions

Temperature control is the single most important factor in peptide stability. Follow these guidelines to preserve potency:

  • Lyophilized (unreconstituted): Refrigerate at 36-46 F (2-8 C). Stable for months to years. Can be stored at room temperature short-term during shipping.
  • Reconstituted: Always refrigerate at 36-46 F (2-8 C). Use within 4-8 weeks. Never leave at room temperature.
  • Long-term storage: Lyophilized peptides can be frozen at -4 F (-20 C) for extended preservation.
  • Protect from light: Store in original packaging or wrap vials in foil to prevent UV degradation.
  • Avoid freeze-thaw cycles: If you need multiple draws over time, aliquot the reconstituted solution into smaller vials.
Sterile technique

Maintaining sterility prevents bacterial contamination that can degrade peptides and pose safety risks:

  • Always swab vial tops and injection sites with alcohol pads
  • Use a new, sterile needle for each draw and each injection
  • Work in a clean, well-lit environment
  • Never touch the needle tip or allow it to contact unsterilized surfaces
  • Dispose of used needles in a proper sharps container - never recap or reuse
  • Rotate injection sites to prevent lipohypertrophy and tissue irritation
Important safety notes
  • Research peptides are sold for research purposes only and are not FDA-approved for human use
  • Always consult a qualified healthcare professional before beginning any protocol
  • Start with the lowest recommended research dose and titrate gradually
  • Be aware of potential contraindications with existing medical conditions or medications
  • Discontinue use and consult a professional if unexpected adverse effects occur
  • Source peptides only from reputable suppliers that provide third-party purity testing (COA)

Frequently Asked Questions

Peptides and steroids are fundamentally different molecules with different mechanisms. Steroids are lipid-based hormones derived from cholesterol that directly enter cells and bind to intracellular receptors to alter gene expression. Peptides are amino acid chains that bind to cell surface receptors and trigger signaling cascades. Steroids tend to have broad, systemic effects with significant side effect profiles, while peptides are generally more targeted in their action. Most importantly, peptides like GH secretagogues work by stimulating the body's own production of hormones rather than introducing exogenous hormones directly.
Onset varies widely by peptide type and protocol. Some peptides like BPC-157 may show initial effects within days for acute injuries, while others like GH secretagogues typically require 4-8 weeks of consistent use before significant changes become apparent. Metabolic peptides like semaglutide usually show measurable effects within 2-4 weeks. Longevity-focused peptides like Epitalon work on cellular timescales that may take months to assess. As a general rule, allow at least 4-12 weeks for a full evaluation of any peptide protocol.
Yes, combining peptides (stacking) is common in research protocols. Some combinations are synergistic - for example, pairing a GHRH analog (CJC-1295) with a GHRP (Ipamorelin) produces significantly greater GH release than either alone. Similarly, BPC-157 and TB-500 are often combined for enhanced tissue repair. However, not all combinations are beneficial, and some may interfere with each other. It's important to understand the mechanism of each peptide and potential interactions. Pre-mixed blends simplify administration for commonly paired peptides.
Like any bioactive compound, peptides can produce side effects. Common and generally mild effects include injection site reactions (redness, swelling), water retention, temporary changes in blood sugar levels, and flushing. Specific peptides may have specific side effects - for example, GH secretagogues can increase hunger (especially GHRP-6), and metabolic peptides like semaglutide can cause nausea. Most side effects are dose-dependent and can be managed through proper titration. Starting with the lowest effective dose and gradually increasing is the standard approach to minimize adverse reactions.
Cycling - alternating periods of use with planned breaks - serves multiple purposes. First, it prevents receptor desensitization, where receptors become less responsive after prolonged stimulation. Second, it allows the body's natural feedback systems to recalibrate, preventing suppression of endogenous production. Third, it can enhance long-term efficacy by maintaining receptor sensitivity. A typical cycle might be 8-12 weeks on followed by 4-8 weeks off, though specific timing varies by peptide. Some peptides like BPC-157 may not require cycling due to their mechanism of action.
Lyophilized (freeze-dried) peptides are relatively stable at room temperature for short periods, making standard shipping generally acceptable. The lyophilization process removes water, which is the primary driver of degradation. However, extended exposure to heat (above 77 F / 25 C) should be avoided. Reconstituted peptides should never be shipped at room temperature. Upon receiving a shipment, refrigerate lyophilized peptides promptly. Most reputable suppliers ship with cold packs during warm months for added protection.
A Certificate of Analysis (COA) is a document from an independent laboratory that verifies the identity, purity, and potency of a peptide. Key metrics include purity percentage (typically >98% for research-grade peptides), molecular weight confirmation via mass spectrometry, and HPLC (high-performance liquid chromatography) analysis. Third-party testing means the analysis was performed by a lab not affiliated with the manufacturer or seller, providing an unbiased quality assessment. Always request current COAs when sourcing research peptides.

Peptide Glossary

99 Terms
99 terms
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Adverse Event
Any undesirable experience or side effect associated with the use of a peptide or drug, whether or not it is directly caused by the substance. Adverse events are documented in research to assess safety profiles.
Agonist
A molecule that binds to a receptor and activates it, triggering a biological response. Many therapeutic peptides are receptor agonists that mimic the action of the body's natural signaling molecules.
Aliquot
A measured portion of a reconstituted solution, divided into smaller volumes for individual use. Aliquoting reduces the number of times the main vial is punctured, preserving sterility and extending shelf life.
Amino Acid
An organic molecule containing an amine group and a carboxylic acid group. Twenty standard amino acids serve as the building blocks of peptides and proteins, linked together via peptide bonds.
AMPK
AMP-activated protein kinase, a master energy sensor that regulates cellular metabolism. When activated, AMPK promotes fat oxidation, glucose uptake, and mitochondrial biogenesis. Peptides like MOTS-c and AICAR activate this pathway.
Angiogenesis
The formation of new blood vessels from pre-existing vasculature. Several peptides promote angiogenesis to enhance wound healing and tissue repair by improving blood supply to damaged areas.
Antagonist
A molecule that binds to a receptor and blocks its activation, preventing the natural ligand from producing its effect. Antagonist peptides are used to inhibit specific biological pathways.
Apoptosis
Programmed cell death, a controlled process that eliminates damaged or unnecessary cells. Unlike necrosis, apoptosis is orderly and does not trigger inflammation. Some peptides modulate apoptotic pathways for therapeutic benefit.
Aspiration
The practice of pulling back slightly on the syringe plunger after inserting the needle to check for blood, which would indicate the needle has entered a blood vessel. Modern guidelines for subcutaneous injections generally consider aspiration unnecessary.
Autophagy
The cellular process of recycling damaged organelles and misfolded proteins. Autophagy acts as a quality control mechanism and is associated with longevity. Fasting and certain peptides can upregulate autophagy.

B

Bacteriostatic Water (BAC Water)
Sterile water containing 0.9% benzyl alcohol as a preservative that inhibits bacterial growth. BAC water is the standard solvent for reconstituting lyophilized peptides and allows for multiple draws from a single vial.
Bioavailability
The proportion of an administered substance that enters systemic circulation and is available for biological activity. Bioavailability varies significantly by route of administration - intravenous is 100%, while subcutaneous and oral routes are lower.
Blend
A single vial containing two or more peptides combined in a pre-mixed formulation. Blends simplify administration by reducing the number of injections needed, such as a BPC-157/TB-500 blend for recovery.
Blood-Brain Barrier
A highly selective semipermeable membrane that separates circulating blood from the brain's extracellular fluid. The BBB restricts most peptides from entering the brain, which is why intranasal delivery is used for cognitive peptides like Semax and Selank.
BPC (Body Protection Compound)
A designation for peptides derived from a protective protein found in human gastric juice. BPC-157, the most studied variant, is a 15-amino-acid peptide researched for its wound-healing, anti-inflammatory, and cytoprotective properties.

C

Circadian Rhythm
The body's approximately 24-hour internal clock that regulates sleep-wake cycles, hormone secretion, and metabolism. Many peptide protocols are timed around circadian patterns - for example, GH secretagogues are often dosed before sleep to align with natural GH pulsatility.
Clinical Trial
A structured research study conducted in human participants to evaluate the safety, efficacy, and optimal dosing of a drug or peptide. Clinical trials progress through phases I-IV, each with increasing scope and participant numbers.
Cold Chain
The unbroken series of temperature-controlled storage and transport conditions required to maintain the stability of temperature-sensitive peptides. Breaking the cold chain can cause peptide degradation and loss of potency.
Collagen Synthesis
The biological process of producing collagen, the most abundant structural protein in the body. Peptides like GHK-Cu and BPC-157 stimulate collagen synthesis to support wound healing, tendon repair, and skin rejuvenation.
Concentration
The amount of peptide dissolved per unit volume of solution, typically expressed in mcg/mL or mg/mL. Concentration is determined by the amount of peptide in the vial divided by the volume of diluent added during reconstitution.
Contraindication
A specific condition or factor that makes the use of a particular peptide or treatment inadvisable due to the risk of harm. For example, active cancer is often listed as a contraindication for growth-promoting peptides.
Cycle
A defined period of peptide use followed by a planned break. Cycling helps prevent receptor desensitization, maintains the body's natural feedback loops, and can enhance long-term efficacy.
Cytokine
A broad category of small signaling proteins released by cells that regulate immunity, inflammation, and hematopoiesis. Cytokines include interleukins, interferons, and tumor necrosis factors.
Cytoprotection
The process of protecting cells from harmful agents or stressful conditions. Cytoprotective peptides like BPC-157 shield cells from oxidative stress, inflammation, and toxic damage.

D

DAC (Drug Affinity Complex)
A chemical modification that extends a peptide's half-life by allowing it to bind to albumin in the blood. CJC-1295 with DAC has a half-life of approximately 6-8 days compared to roughly 30 minutes for the unmodified version.
Denaturation
The loss of a peptide's three-dimensional structure due to heat, agitation, or chemical exposure. Denatured peptides lose their biological activity and cannot be restored to their original conformation.
Desensitization
A reduction in receptor responsiveness following prolonged or repeated exposure to an agonist. Desensitization is why many peptide protocols include cycling or washout periods to maintain efficacy.
Dose-Response
The relationship between the amount of a peptide administered and the magnitude of the biological effect produced. Understanding this curve helps identify the minimum effective dose and the point of diminishing returns.

E

Endogenous
Originating or produced within the body. Endogenous peptides are those your body naturally synthesizes, such as insulin or growth hormone.
Epithalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for its ability to activate telomerase, potentially extending telomere length and promoting cellular longevity. Also known as Epitalon or Epithalone.
Exogenous
Originating or introduced from outside the body. Exogenous peptides are administered externally, whether by injection, orally, or through other routes.

F

FDA
The U.S. Food and Drug Administration, the federal agency responsible for regulating drugs, biologics, and medical devices. Most research peptides are not FDA-approved for human use and are sold for research purposes only.
Fibroblast
A connective tissue cell responsible for producing the extracellular matrix, including collagen and other structural proteins. Fibroblasts are key players in wound healing and tissue repair, and are stimulated by peptides like GHK-Cu.
First-Pass Metabolism
The rapid metabolism of a substance by the liver and gut wall after oral ingestion, before it reaches systemic circulation. This effect significantly reduces the bioavailability of most peptides taken orally.
Foaming
The formation of bubbles during reconstitution caused by vigorous mixing or agitation. Foaming can denature peptides by creating air-liquid interfaces that disrupt molecular structure. Always reconstitute by gently rolling or swirling the vial.
Freeze-Thaw Cycle
The process of freezing and then thawing a reconstituted peptide solution. Repeated freeze-thaw cycles can degrade peptide integrity through ice crystal formation and should be minimized by using aliquots.

G

GH (Growth Hormone)
A 191-amino-acid protein hormone secreted by the anterior pituitary gland that stimulates growth, cell reproduction, and regeneration. GH acts both directly and through its mediator IGF-1 to influence metabolism, body composition, and tissue repair.
GHRH
Growth hormone-releasing hormone, a hypothalamic peptide that stimulates the pituitary gland to synthesize and secrete growth hormone. Synthetic GHRH analogs like CJC-1295 and Sermorelin are used to promote natural GH production.
GHRP
Growth hormone-releasing peptide, a class of synthetic peptides that stimulate GH release by acting on the ghrelin receptor (GHS-R1a) in the pituitary. Examples include GHRP-2, GHRP-6, and Ipamorelin.
Growth Factor
A naturally occurring protein that stimulates cell proliferation, differentiation, and survival. Examples include IGF-1, EGF, and VEGF. Many peptides exert their effects by stimulating the release or activity of specific growth factors.

H

Half-Life
The time required for the concentration of a peptide in the body to decrease by half. Half-life determines dosing frequency - shorter half-lives require more frequent administration to maintain therapeutic levels.

I

IGF-1
Insulin-like growth factor 1, a hormone structurally similar to insulin that mediates many of growth hormone's anabolic effects. IGF-1 promotes tissue growth, muscle protein synthesis, and cell survival.
In Vitro
Latin for "in glass" - experiments conducted outside a living organism, typically in a test tube, petri dish, or cell culture. In vitro studies are an early stage of research and do not always predict in vivo outcomes.
In Vivo
Latin for "in the living" - experiments conducted within a living organism, such as animal or human studies. In vivo research provides more relevant data about how a peptide behaves in biological systems.
Injection Site Rotation
The practice of alternating injection locations (e.g., rotating between abdomen, thigh, and upper arm) to prevent tissue damage, lipohypertrophy, and inconsistent absorption at any single site.
Interleukin
A group of cytokines first discovered to be expressed by leukocytes (white blood cells). Interleukins regulate immune cell differentiation and activation and play key roles in inflammatory and anti-inflammatory responses.
Intramuscular (IM)
An injection administered directly into a muscle, such as the deltoid or gluteus. IM injections generally provide faster absorption than subcutaneous injections due to the higher blood flow in muscle tissue.
Intranasal
Administration through the nasal mucosa via a spray or drops. This route allows certain peptides to bypass the blood-brain barrier more effectively, making it common for cognitive and neuroprotective peptides.
Intravenous (IV)
Administration directly into a vein, providing immediate 100% bioavailability. IV delivery is typically reserved for clinical settings due to the expertise and sterile conditions required.
IU (International Units)
A standardized unit of measurement for biologically active substances based on their measured biological effect rather than mass. Commonly used for HGH, HCG, and other peptides where potency varies between preparations.

L

Ligand
Any molecule that binds to a specific receptor. Peptides function as ligands when they bind to their target receptors to initiate downstream signaling cascades.
Lipohypertrophy
A localized accumulation of fat tissue beneath the skin caused by repeated injections at the same site. It can impair peptide absorption and is prevented through consistent injection site rotation.
Loading Phase
An initial period of higher or more frequent dosing designed to rapidly achieve effective tissue or blood levels of a peptide before transitioning to a lower maintenance dose.
Lyophilized
Freeze-dried into a dry powder form for long-term storage stability. Most research peptides are supplied lyophilized and must be reconstituted with bacteriostatic water before use.

M

Maintenance Phase
The ongoing dosing period following a loading phase, using a reduced dose or frequency sufficient to sustain the desired effect over the long term.
mcg (Microgram)
A unit of mass equal to one-millionth of a gram (0.001 mg). Many peptides are dosed in micrograms due to their high biological potency at very small quantities.
Melanotan
A class of synthetic peptide analogs of alpha-melanocyte-stimulating hormone (α-MSH). Melanotan I and Melanotan II stimulate melanogenesis (skin tanning) and, in the case of MT-II, also influence sexual arousal and appetite.
mg (Milligram)
A unit of mass equal to one-thousandth of a gram (1,000 mcg). Some peptides such as BPC-157 and TB-500 are commonly dosed in milligrams rather than micrograms.
Mitochondria
Membrane-bound organelles found in nearly all eukaryotic cells that generate most of the cell's ATP through oxidative phosphorylation. Mitochondrial function declines with age, and peptides like SS-31 and MOTS-c target mitochondria to improve cellular energy production.
MOD GRF
Modified growth hormone-releasing factor (1-29), also known as CJC-1295 without DAC. It is a truncated and modified version of GHRH with improved stability and a half-life of approximately 30 minutes, designed for pulsatile GH stimulation.
mTOR
Mechanistic target of rapamycin, a kinase that serves as a central regulator of cell growth, proliferation, and protein synthesis. mTOR activation promotes muscle growth and recovery, while its inhibition is associated with longevity and autophagy.

N

NAD+
Nicotinamide adenine dinucleotide, a coenzyme essential for cellular energy metabolism and DNA repair. NAD+ levels decline with age, and its supplementation or promotion via peptides is a key strategy in longevity research.
Negative Feedback
A regulatory mechanism where the output of a biological process inhibits further production. For example, exogenous growth hormone can suppress the body's own GH secretion through negative feedback on the pituitary.
Neuroprotection
The mechanisms and strategies used to protect neural tissue from damage and degeneration. Neuroprotective peptides like Cerebrolysin, Semax, and Selank help preserve neuronal function following injury, ischemia, or neurodegenerative processes.
NF-κB
Nuclear factor kappa-light-chain-enhancer of activated B cells, a transcription factor that controls the expression of genes involved in inflammation, immunity, and cell survival. Many anti-inflammatory peptides work by inhibiting NF-κB signaling.

O

Off-Label
The use of a drug or peptide for a purpose, population, or dosing regimen not specified in its official FDA-approved labeling. Many peptides used in clinical practice are prescribed off-label based on emerging research.
Oral Bioavailability
The fraction of an orally administered substance that reaches systemic circulation in active form. Most peptides have very low oral bioavailability due to enzymatic degradation in the gut and first-pass metabolism in the liver.
Oxidative Stress
An imbalance between the production of reactive oxygen species (free radicals) and the body's ability to neutralize them with antioxidants. Chronic oxidative stress contributes to aging and disease, and several peptides possess antioxidant properties.

P

Peer-Reviewed
Research that has been evaluated by independent experts in the same field before publication in a scientific journal. Peer review is a quality control process that helps ensure the validity and rigor of published findings.
Peptide
A short chain of amino acids linked by peptide bonds, typically ranging from 2 to 50 amino acids in length. Peptides serve as signaling molecules, hormones, and neurotransmitters throughout the body.
Pharmacodynamics
The study of what a drug does to the body - its mechanism of action, receptor binding, downstream effects, and the relationship between concentration and response.
Pharmacokinetics
The study of what the body does to a drug - how it is absorbed, distributed, metabolized, and excreted (ADME). Pharmacokinetics determines half-life, bioavailability, and optimal dosing schedules.
Placebo-Controlled
A type of clinical trial in which one group receives the active substance and another receives an inert placebo, allowing researchers to isolate the true effect of the treatment from the placebo response.
Polypeptide
A single chain of amino acids, typically longer than a peptide (50+ amino acids) but not yet folded into the complex three-dimensional structure that defines a protein.
Preclinical
The stage of research conducted before human clinical trials, including in vitro studies and animal models. Preclinical data supports safety and efficacy but does not guarantee the same outcomes in humans.
Protein
A large, complex macromolecule composed of one or more polypeptide chains folded into a specific three-dimensional shape. Proteins perform a vast array of functions including enzymatic catalysis, structural support, and cell signaling.
Pulsatile Release
The secretion of a hormone or peptide in intermittent bursts rather than a continuous stream. Growth hormone, for example, is naturally released in pulsatile fashion, which is why some GH secretagogues aim to mimic this pattern.

R

Receptor
A protein structure on or within a cell that binds to specific molecules (ligands) and initiates a cellular response. Peptides exert their effects by binding to specific receptors on target tissues.
Reconstitution
The process of adding a diluent (typically bacteriostatic water) to a lyophilized peptide powder to create an injectable solution. Proper reconstitution requires gently directing the water down the vial wall to avoid foaming.
Related Protocols
Peptide protocols that share complementary mechanisms, target similar conditions, or are commonly used together. Reviewing related protocols helps identify potential synergies and inform comprehensive research plans.

S

Secretagogue
A substance that stimulates the secretion of another substance. Growth hormone secretagogues (like Ipamorelin and GHRP-6) stimulate the pituitary gland to release its own growth hormone rather than providing exogenous GH directly.
Sequence
The specific linear order of amino acids in a peptide or protein chain. The sequence determines the molecule's three-dimensional structure and biological activity.
Sharps Container
A rigid, puncture-resistant container designed for the safe disposal of used needles and syringes. Proper sharps disposal is essential for safety and is often required by local regulations.
Shelf Life
The duration a peptide remains stable and effective under specified storage conditions. Lyophilized peptides typically last months to years refrigerated, while reconstituted solutions generally remain stable for 4-8 weeks.
Sirtuin
A family of NAD+-dependent deacetylase enzymes (SIRT1-SIRT7) involved in regulating metabolism, DNA repair, inflammation, and aging. Sirtuin activation is a key target in longevity research.
Stack
The concurrent use of two or more individual peptides (from separate vials) as part of a coordinated protocol. Stacking is done to leverage complementary mechanisms of action for a combined therapeutic effect.
Sterile Technique
A set of practices designed to minimize contamination during reconstitution and injection, including swabbing vial tops with alcohol, using new needles for each draw, and working in a clean environment.
Subcutaneous (SC)
An injection administered into the fatty tissue layer just beneath the skin, typically in the abdomen, thigh, or upper arm. This is the most common route for peptide administration due to its ease of use and sustained absorption profile.
Synergy
The phenomenon where two or more peptides produce a combined effect greater than the sum of their individual effects. For example, combining a GHRH analog with a GHRP creates synergistic GH release.

T

Tachyphylaxis
A rapid decrease in therapeutic response to a drug after repeated doses in a short period. Tachyphylaxis is a more acute form of desensitization and is particularly relevant for peptides like Melanotan II.
Telomerase
An enzyme that adds repetitive nucleotide sequences to the ends of chromosomes (telomeres), counteracting the shortening that occurs with each cell division. The peptide Epitalon is studied for its potential to activate telomerase.
Telomere
Protective caps of repetitive DNA sequences at the ends of chromosomes that prevent degradation during cell division. Telomeres shorten with age, and their length is considered a biomarker of biological aging.
Thymosin
A family of small proteins originally isolated from the thymus gland that play important roles in immune regulation. Thymosin Alpha-1 is used for immune modulation, while Thymosin Beta-4 (TB-500) is researched for tissue repair and wound healing.
Titration
The practice of gradually increasing or adjusting a peptide dose over time to find the optimal individual response while minimizing side effects. Titration is especially important for peptides with strong dose-dependent effects.
TNF
Tumor necrosis factor, a pro-inflammatory cytokine produced primarily by macrophages. TNF plays a central role in systemic inflammation, and several peptides exert anti-inflammatory effects by downregulating TNF production.
Topical
Application directly to the skin or a mucous membrane surface. Some peptides like GHK-Cu are formulated as topical creams or serums for localized effects such as wound healing or skin rejuvenation.

U

U-100 Syringe
An insulin syringe calibrated at 100 units per milliliter, commonly used for peptide injections. The fine gauge needles (28-31G) are ideal for subcutaneous administration and allow precise measurement of small volumes.

V

Vial
A small glass or plastic container used to store lyophilized or reconstituted peptides. Vials are sealed with a rubber stopper that allows needle penetration for reconstitution and withdrawal of doses.

W

Washout Period
A planned break between peptide cycles during which the compound is fully cleared from the body. Washout periods help restore receptor sensitivity and allow the body's endogenous systems to recalibrate.
No terms match your search.